Menu
Family name, First name: Lämsä, Karri
Researcher unique identifier(s): ORCID ID 0000-0002-4609-1337
Scopus ID: 6602917702
Google Scholar: https://scholar.google.com/citations?user=KX02RE8AAAAJ&hl=en&oi=ao
ResearchGate: https://www.researchgate.net/profile/Karri-Lamsa
Linkedin: https://hu.linkedin.com/in/karri-l%C3%A4ms%C3%A4-62a01595
Nationality: Finnish
2020 Dr MTA (Hungary)
2006 Docent (Adjunct Professor) in Medical Faculty, University of Helsinki (Finland)
2000 Ph.D. in Neurophysiology, Dept. of Animal Physiology, University of Helsinki, Finland. Supervisors Prof. Kai Kaila, Prof. Tomi Taira
1995 M.Sc. in Animal Physiology, University of Helsinki. Supervisor Prof. Kai Kaila
-03/2015-06/2022 Research Professor in the Neuroscience Program of the Hungarian Academy of Science (NAP).
-03/2021 Senior Researcher, SzTE
-01/2013- 3/2015 MRC Senior Scientist of the MRC Anatomical Neuropharmacology Unit, University of Oxford, UK
-9/2007-12/2012 Principal Investigator, Wellcome Trust Career Development Fellow in the Dept. of Pharmacology, University of Oxford, UK
-10/2004-8/2007 Research Fellow, Laboratory of Synaptic Imaging, Institute of Neurology, UCL, UK
-10/2002-09/2004 The Wellcome Trust Travelling Research Fellow. Department of Clinical and Experimental Epilepsy, Institute of Neurology, UCL, UK
-4/2002-09/2002 Postdoctoral fellow, Department of Clinical and Experimental Epilepsy, Institute of Neurology, UCL, UK
-10/2000-3/2002 Research fellow, Department of Biosciences, Division of Animal Physiology, and Institute of Biotechnology, Univ. Helsinki, Finland
-3/1997 – 9/1997 Visiting Research Assistant, INSERM U-29, Hôpital de Port Royal, Paris, France
-4/1995-9/2000 Junior lecturer, Department of Biosciences, Division of Animal Physiology, Univ. Helsinki, Finland
•UK: Wellcome Trust Travelling Research Fellowship 10/02-09/04 (£103,645); Wellcome Trust Research Career Development Fellowship 09/07-08/12 (£904,112); John Fell OUP Funds (University of Oxford) Research Development Grant 04/10-04/12 (£35,500); The Physiological Society, International Junior Research Grant 09/10 (£5,000); MRC Senior Scientist, MRC Anatomical Neuropharmacology Unit, University of Oxford 09/12-03/15 (£215,739)
•Finland: Jenny and Antti Wihuri foundation 10/95 (40.000 FMK); The Academy of Finland grant for research work abroad 01/02-12/03 (EUR 51.000)
•Hungary: The Hungarian Academy of Sciences (MTA) 01/01/15-31/12/2017 (199,958,000 HUF); MTA) 01/01/18-31/12/2021 (120,000,000 HUF); Centre of excellence fund (University of Szeged) 01/10/18-31/09/2021 (30,000,000 HUF); OTKA project grant 01/09/18-31/08/2022 (46,000,000 HUF); OTKA project grant K 01/01/21-31/12/2024 (48,000,000 HUF)
Number of Postdocs (total 7), supervised PhD students (4), Master Students (9), international Ph.D. student visitors with external funding to visit our lab (5). Peer-reviewer for academic theses (total 19).
(Finland) •Junior lecturer in Univ. Helsinki 1995-2000
•Visiting teacher in “Neuronal Signaling and Plasticity lecture series” in University of Helsinki (2004-2020)
(UK) •Annual Plymouth Microelectrode Workshop funded by the Physiological Society UK (one week per year) (2006-2021)
•Oxford University (2008-2014): Annual lectures and practicals
(Hungary) • A neuroscience lecture series in English for spring term 2022, SzTE
-(FENS, 2019) Organiser of the Symposium “Human electrophysiology in health and disease” in FENS Regional Meeting (10-13 July) in Belgrad, Serbia
-(FENS, 2017) Organiser and host of the Symposium in “Human-specific cortical microcircuit function and structure”, FENS Regional Meeting (20-23 September) in Pecs, Hungary
-(UK MRC, 2013) Organizer of the MRC Anatomical Neuropharmacology Science Day (29 May) in Oxford University, UK
•(Hungary) Member of the review panel of the Hungarian Scientific Research Fund (OTKA) in the field of Neurosciences; Member of the internal evaluation committee of the Hungarian Scientific Research Fund (OTKA) in Neurosciences
•(Finland) University of Helsinki, assessing applications for Docentship (adjunct professor)
•(France) Member of external scientific evaluation committee for AERES (Evaluation Agency for Research and Higher education) for research groups in Institut du Fer a Moulin, Paris France; Sorbonne University Paris, assessing habilitation theses
•(Poland) Member of the Life Sciences review panel of the National Science Centre
•(Pakistan) Evaluating Faculty Professorship Promotions for NUS
•(UK) Member of interview and advisory committee for Wellcome Trust/NIH PhD Program
•Guest Editor in Neuropharmacology special issue “Synaptic Plasticity and Interneurons”, Autumn 2010
•Member of Editorial board in Frontiers in Synaptic Neuroscience, March 2012-
•Reviewing Editor in Frontiers in Molecular Neuroscience, Apr 2015-
•Guest Editor in Frontiers in Neural Circuits special issue “Calcium-permeable AMPAR-mediated plasticity”, Autumn 2018
•The Society for Neuroscience, USA
•The Physiological Society, United Kingdom
•The Physiological Society of Finland
•Member of Hungarian Academy of Science’s public body
•Highlighted in the issue – PLOS Biology (Jan, 2017)
•This Week in The Journal – Journal of Neuroscience (27 Jan 2010)
• From The Editors; Nature Reviews Neuroscience 8, 649 (September 2007).
•Editor’s choice, Variation on Synaptic Potentiation. Science. STKE, tw76 (2007)
>50 international symposia and research seminars
Biological Psychiatry, BMC Neuroscience, Brain, Cell Reports, Cerebral Cortex, Cold Spring Harbour Protocols, eNeuro, Epilepsia, The European Journal of Neuroscience, Frontiers in Neural Circuits, Hippocampus, The Journal of Comparative Neurology, The Journal of Neurophysiology, The Journal of Neuroscience, The Journal of Physiology (London), Molecular Neurobiology, Nature, Nature Communications, Nature Neuroscience, Nature Reviews, Neurobiology of Disease, Neuron, Neuroscience, PLoS Biology, PLoS ONE, PNAS (Proceedings of the National Academy of Sciences), Scientific Reports
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 739593. HCEMM supported by EU Programme: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions. Project starting date was 1 April 2017.
